论文信息 - Bevacizumab for children with relapsed & refractory high-risk neuroblastoma (RR-HRNB): Results of the BEACON-neuroblastoma randomized phase II trial - A European ITCC-SIOPEN trial - 字舞流文

Bevacizumab for children with relapsed & refractory high-risk neuroblastoma (RR-HRNB): Results of the BEACON-neuroblastoma randomized phase II trial - A European ITCC-SIOPEN trial

B. Morland | K. Wheatley | R. Ladenstein | G. Laureys | D. Valteau‐Couanet | V. Moroz | A. Castellano | V. Castel | S. Vaidya | A. Pearson | K. Nysom | N. Gerber | C. Owens | D. Murphy | L. Moreno | M. Elliott | Marion Gambart | N. van Eijkelenburg | Estelle Thebaud